Reviva Pharmaceuticals Holdings, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Reviva Pharmaceuticals Holdings, Inc.
Pharma and the US biotech will target key regulators of cellular metabolism with focus on immune and neurological disorders. Royalty Pharma buys portion of PTC’s royalty rights to risdiplam, under development at Roche.
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Medtronic appoints new CFO; EndoChoice elevates William Enquist to chairman post; Andrew Bindman named new Agency for Healthcare Research and Quality director; Nexstim seeks new permanent CEO.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced November-December 2015.
Drug Discovery Tools
- Drug Discovery Tools
- Other Names / Subsidiaries
- Reviva Pharmaceuticals, Inc.